Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X about a paper he co-authored with colleagues published in Leukemia Research:
“Applicability of current prognostication models for MDS patients with…
Talha Badar: Current Prognostication Models for MDS Patients with DDX41 Mutation
